EPAM Systems raised its annual earnings forecast for the third time this year as businesses spend more to modernize their systems for artificial intelligence, sending shares of the IT consultancy firm... ...

The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's drug Caplyta as an add-on treatment for adults with major depressive disorder, the company said on Thursday. ...

PENN Entertainment and Walt Disney's ESPN have agreed to end their exclusive U.S. online sports betting partnership, effective December 1, the companies said on Thursday. ...

Medical device maker Insulet on Thursday posted third-quarter results that surpassed Wall Street's expectations on strong demand for its wearable insulin pumps, which eliminate the need for daily inje... ...

HSBC on Thursday issued a set of new, softer near-term climate targets for sectors such as oil and gas in response to the slow pace of change in the real economy. ...

Metropolis Technologies, a U.S. operator of parking lots that uses artificial intelligence and computer vision to recognize vehicles, has raised $1.6 billion in fresh capital to extend its technology ... ...

Moderna lowered the top end of its 2025 revenue forecast by $200 million on Thursday, citing weaker-than-expected sales of its COVID-19 vaccine in the U.S. as Americans struggled to access the shots. ...

Under Armour forecast annual revenue and profit below Wall Street estimates on Thursday, as the sportswear maker faces a demand decline and rising tariff costs. ...

Telecom Italia (TIM) would welcome any consolidation in the country's telecoms market, even if competitors should make the first move, the head of Italy's former phone monopoly said on Thursday. ...

ConocoPhillips beat Wall Street estimates for third-quarter profit on Thursday, as higher oil and gas production and cost-cutting efforts helped offset lower commodity prices. ...